Theramyt Novobiologics Company
Theramyt develops therapies for disease areas such as oncology, rheumatoid arthritis, diabetes, and metabolic disorders.
Investors
Founded Date:
2013
Total Funding:
$1.5M
Investor Type:
For Profit
Employee Number:
11-50
Funding Status:
Early Stage Venture
Technology:
Biologics
Last Funding Type:
Seed
Investors Number:
5
Last Funding Date:
2013-10-11
Industry:
PharmTech
Headquarters:
Bengaluru, Karnataka, India
Estimated Revenue:
$1M to $10M